UBS Group’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
– Sell
-400
Closed -$19K – 10873
2013
Q4
$19K Buy
+400
New +$18.7K ﹤0.01% 8223

Other funds holding XRAY

UBS Group's XRAY Position: Q3 2026 in Review

UBS Group reduced its Dentsply Sirona (XRAY) stake by 28% in Q3 2026, selling an estimated $6.48M and leaving 1,407,872 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3168.

UBS Group first reported a position in XRAY in Q2 2013 and has held it in 54 quarters since. The position peaked at $26.7M in Q1 2026. 377 funds tracked by Wall St. Rank hold XRAY as of Q3 2026.

  • UBS Group held 1,407,872 shares of Dentsply Sirona worth $12.5M as of Q3 2026.
  • UBS Group sold 559,108 Dentsply Sirona shares in Q3 2026, an estimated $6.48M.
  • Dentsply Sirona made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #3168 holding.
  • UBS Group first reported a position in Dentsply Sirona in Q2 2013 and has held it in 54 quarters since.
  • UBS Group's Dentsply Sirona position peaked at $26.7M in Q1 2026.
  • 377 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.